Riskpilot← Back to searchSign inGet full accessGENESEQUE AS
ASActiveOrg 992322551Att Jarle Kotsbak Veimester Kroghs Gate 4D, 7043 TrondheimResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20080 employees
Revenue 2024
NOK 0
EBITDA margin
—
+57% vs 2023
Equity ratio
25.3%
Financial strength
Net profit 2024
NOK -59K
+57% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -59K | +57% |
| Net profit | NOK -59K | +57% |
| Total assets | NOK 1,1M | -5% |
| Equity | NOK 268K | -18% |
| Employees | 0 | — |
Legal name
GENESEQUE AS
Org number
992322551
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16. februar 2008
Share capital
NOK 347 562
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Jarle kotsbak
Company purpose
Fremstilling og salg av laboratorieutstyr og andre produkter som naturlig hører sammen med dette samt elektronisk produksjonsutstyr, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretagende.
Address
Att Jarle Kotsbak Veimester Kroghs Gate 4D, 7043 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 145 | 812 | 1 075 | 1 346 | 1 721 | 837 | 0 | 0 | 0 | 0 | 256 | 320 | 905 | 0 | 0 | 0 | 0 |
| Staff expenses | −600 | −1 493 | −1 753 | −1 675 | −1 533 | −643 | 9 | −2 | −0 | −0 | −215 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −817 | −1 477 | −1 564 | −2 834 | −4 212 | −2 214 | −1 439 | −406 | −317 | −360 | −116 | 237 | 829 | −27 | −179 | −137 | −59 |
| Depreciation & amort. | −50 | −300 | −300 | −464 | −473 | −423 | −318 | −15 | −6 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −867 | −1 777 | −1 864 | −3 298 | −4 686 | −2 637 | −1 757 | −421 | −323 | −360 | −116 | 237 | 829 | −27 | −179 | −137 | −59 |
| Net financials | −2 | 3 | −32 | −203 | −31 | 5 | 1 | −3 | −1 | −13 | −11 | −10 | 0 | 0 | 0 | 0 | −0 |
| Profit before tax | −869 | −1 775 | −1 896 | −3 501 | −4 716 | −2 632 | −1 757 | −424 | −324 | −373 | −126 | 227 | 829 | −27 | −179 | −137 | −59 |
| Tax | −168 | −488 | −624 | −693 | −1 078 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −701 | −1 287 | −1 271 | −2 808 | −3 639 | −2 632 | −1 757 | −424 | −324 | −373 | −126 | 227 | 829 | −27 | −179 | −137 | −59 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 497 | 2 659 | 2 342 | 2 550 | 6 076 | 2 856 | 943 | 424 | 61 | 17 | 121 | 228 | 1 284 | 1 287 | 1 221 | 1 121 | 1 060 |
| Equity | 1 002 | 715 | −556 | −2 364 | 5 176 | 2 544 | 787 | 363 | 39 | −334 | −461 | −160 | 669 | 643 | 465 | 327 | 268 |
| Long-term debt | 1 000 | 950 | 900 | 3 146 | 0 | 0 | 0 | 0 | 0 | 260 | 242 | 288 | 122 | 152 | 259 | 259 | 259 |
| Short-term debt | 495 | 994 | 1 998 | 1 768 | 900 | 312 | 156 | 61 | 22 | 92 | 339 | 101 | 492 | 491 | 497 | 534 | 533 |
| Total debt | 1 495 | 1 944 | 2 898 | 4 914 | 900 | 312 | 156 | 61 | 22 | 352 | 581 | 388 | 615 | 644 | 756 | 793 | 792 |
EBITDA margin
-5926100.0%
This company
15.8%
Market median
-37507062% vs market
20082024
Equity ratio
25.3%
This company
38.2%
Market median
-34% vs market
20082024
Return on equity
-22.1%
This company
18.4%
Market median
-220% vs market
20082024
Net profit margin
-5931500.0%
This company
8.1%
Market median
-73228495% vs market
20082024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20082024
Debt / equity
2.95×
This company
0.62×
Market median
-376% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Micronax As | Company | 60.4% | 60.4% | 2022 |
| Individual | 15.2% | 15.2% | 2022 | |
Prosphere As | Company | 10.1% | 10.1% | 2022 |
| Individual | 5.8% | 5.8% | 2022 | |
| Individual | 5.8% | 5.8% | 2022 | |
| Individual | 2.9% | 2.9% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GENESEQUE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jarle Kotsbak | Chairman | 0 companies |